SCHEMBL18397338

SCHEMBL18397338

CCOc1cc(Cc2ccnc(C(=O)NC)c2)cnc1OCc1ccc(C2CC2)nc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 7/20 1.00
PARP1 P09874 1/20 0.38
KDR P35968 3/20 0.38
PDGFRB P09619 1/20 0.38
KIT P10721 1/20 0.38
FLT4 P35916 1/20 0.38
ILK Q13418 1/20 0.38
MAP3K20 Q9NYL2 1/20 0.38
ADORA1 P30542 2/20 0.37
SMYD3 Q9H7B4 1/20 0.36
CNR2 P34972 1/20 0.35
CCR5 P51681 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29859212 1.00 CSF1R (1.00) CSF1RPARP1KDRPDGFRBKIT
SCHEMBL18397204 0.91 CSF1R (0.84) CSF1RPARP1SMYD3CCR5MAPT
SCHEMBL18397285 0.87 CSF1R (1.00) CSF1RKDRPDGFRBKIT
SCHEMBL29859417 0.87 CSF1R (1.00) CSF1RKDRPDGFRBKIT
SCHEMBL18397041 0.77 CSF1R (0.62) CSF1RKITKDM4E
SCHEMBL29859010 0.77 CSF1R (0.62) CSF1RKITKDM4E
SCHEMBL18397186 0.77 CSF1R (0.83) CSF1RKDR
SCHEMBL18397190 0.76 CSF1R (0.61) CSF1RKITCNR2CCR5SMN1; SMN2
SCHEMBL18396998 0.76 CSF1R (1.00) CSF1RKDRPDGFRBKIT
SCHEMBL29858951 0.76 CSF1R (1.00) CSF1RKDRPDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2024-07-04 US claimed
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION 2025-12-23 US disclosed
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2024-07-04 US disclosed
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2022-12-15 US disclosed
CN-107922396-B Colony stimulating factor-1 receptor (CSF-1R) inhibitors 建新公司 2022-08-05 CN disclosed
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION (US) 2022-03-15 US disclosed
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION 2019-01-17 US disclosed
EP-3325471-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS Genzyme Corporation (US) 2018-05-30 EP disclosed
WO-2017015267-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2017-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN CSF1R 1/4885PARP1 3278/4885KDR 138/4885
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CSF1R 1/4885PARP1 3278/4885KDR 138/4885
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CSF1R 1/4885PARP1 3278/4885KDR 138/4885
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN CSF1R 1/4885PARP1 3684/4885KDR 102/4885
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CSF1R 1/4885PARP1 3278/4885KDR 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.